DK0545413T3 - Trans-cyclopentanylpurinanaloger anvendelige som immunosuppressiva - Google Patents

Trans-cyclopentanylpurinanaloger anvendelige som immunosuppressiva

Info

Publication number
DK0545413T3
DK0545413T3 DK92120653T DK92120653T DK0545413T3 DK 0545413 T3 DK0545413 T3 DK 0545413T3 DK 92120653 T DK92120653 T DK 92120653T DK 92120653 T DK92120653 T DK 92120653T DK 0545413 T3 DK0545413 T3 DK 0545413T3
Authority
DK
Denmark
Prior art keywords
trans
immunosuppressants
purine analogs
cyclopentanyl
hydrogen
Prior art date
Application number
DK92120653T
Other languages
Danish (da)
English (en)
Inventor
David R Borcherding
Ronald E Esser
Carl K Edwards Iii
Douglas L Cole Iii
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0545413T3 publication Critical patent/DK0545413T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK92120653T 1991-12-06 1992-12-03 Trans-cyclopentanylpurinanaloger anvendelige som immunosuppressiva DK0545413T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80415391A 1991-12-06 1991-12-06
US96560192A 1992-11-02 1992-11-02

Publications (1)

Publication Number Publication Date
DK0545413T3 true DK0545413T3 (da) 2000-10-09

Family

ID=27122672

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92120653T DK0545413T3 (da) 1991-12-06 1992-12-03 Trans-cyclopentanylpurinanaloger anvendelige som immunosuppressiva

Country Status (17)

Country Link
EP (1) EP0545413B1 (ja)
JP (1) JP3264289B2 (ja)
KR (1) KR100251996B1 (ja)
AT (1) ATE194618T1 (ja)
AU (1) AU658698B2 (ja)
CA (1) CA2084222C (ja)
DE (1) DE69231242T2 (ja)
DK (1) DK0545413T3 (ja)
ES (1) ES2149163T3 (ja)
FI (1) FI109026B (ja)
GR (1) GR3034586T3 (ja)
HU (2) HU9203858D0 (ja)
IL (1) IL103962A (ja)
MX (1) MX9206963A (ja)
NO (1) NO305207B1 (ja)
NZ (1) NZ245342A (ja)
PT (1) PT545413E (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT73412A (en) 1993-06-21 1996-07-29 Merrell Pharma Inc Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
ES2232871T3 (es) * 1996-07-03 2005-06-01 Sumitomo Pharmaceuticals Company, Limited Nuevos derivados de purina.
US6413974B1 (en) 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
US6479487B1 (en) * 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
FR2793794B1 (fr) * 1999-05-21 2001-07-27 Hoechst Marion Roussel Inc Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
US6861524B2 (en) 2000-10-31 2005-03-01 Aventis Pharmaceuticals Inc. Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038479A (en) * 1969-11-17 1977-07-26 Burroughs Wellcome Co. Amino purine derivatives
US4076711A (en) * 1976-04-05 1978-02-28 Schering Corporation Triazolo [4,5-d]-pyrimidines
CA2001715C (en) * 1988-11-14 1999-12-28 Muzammil M. Mansuri Carbocyclic nucleosides and nucleotides
ES2085446T3 (es) * 1990-07-04 1996-06-01 Merrell Pharma Inc Derivados de acido 9-purinil fosfonico.
AU647822B2 (en) * 1990-09-14 1994-03-31 Marion Merrell Dow Inc. Novel carbocyclic adenosine analogs useful as immunosuppressants

Also Published As

Publication number Publication date
NO924691D0 (no) 1992-12-04
PT545413E (pt) 2000-10-31
KR100251996B1 (ko) 2000-09-01
FI925520A (fi) 1993-06-07
HUT62896A (en) 1993-06-28
HU9203858D0 (en) 1993-03-29
FI925520A0 (fi) 1992-12-04
ES2149163T3 (es) 2000-11-01
NO924691L (no) 1993-06-07
CA2084222A1 (en) 1993-06-07
GR3034586T3 (en) 2001-01-31
IL103962A0 (en) 1993-05-13
HU217077B (hu) 1999-11-29
DE69231242T2 (de) 2000-12-21
FI109026B (fi) 2002-05-15
JP3264289B2 (ja) 2002-03-11
EP0545413A1 (en) 1993-06-09
MX9206963A (es) 1993-06-01
NZ245342A (en) 1995-10-26
EP0545413B1 (en) 2000-07-12
AU658698B2 (en) 1995-04-27
NO305207B1 (no) 1999-04-19
ATE194618T1 (de) 2000-07-15
JPH0656835A (ja) 1994-03-01
IL103962A (en) 1997-01-10
CA2084222C (en) 2004-04-06
DE69231242D1 (de) 2000-08-17
AU2975292A (en) 1993-06-10

Similar Documents

Publication Publication Date Title
EP1381366A4 (en) INDOL, AZAINDOL AND RELATED HETEROCYCLIC AMIDOPIPERAZINE DERIVATIVES
DK0654037T3 (da) Enantiomere anti-retrovirus-nukleotidanaloger
FI935150A (fi) Foerfaranden foer diastereoselektiv syntes av nukleosider
ATE144513T1 (de) Pyrrolopyrimidinderivate, ihre herstellung und verwendung
HUP0004082A2 (hu) Adenozinszármazékok, eljárás előállításukra azokat hatóanyagként tartalmazó gyógyszerkészítmények, valamint ilyen hatóanyagok alkalmazása gyógyszerkészítmények előállítására
CA2051012A1 (en) Carbocyclic adenosine analogs useful as immunosupressants
MXPA04001240A (es) Analogos antitumorales.
ATE110382T1 (de) Oxetanocin.
DK0545413T3 (da) Trans-cyclopentanylpurinanaloger anvendelige som immunosuppressiva
FR2389623A1 (ja)
FI925191A0 (fi) Nya oxazolderivat, deras framstaellning och farmaceutiska kompositionerinnehaollande dem
DK0475413T3 (da) Carbocycliske nukleosidanaloge, der kan anvendes som immunsuppressorer
BG60248B2 (en) Process for the preparation of phenoxyethylamine derivatives
HK1060354A1 (en) Variolin derivatives and their use as antitumor agents
MX9203332A (es) Derivados de 2-amino pirimidina -4- carboxamida, su preparacion y su aplicacion en terapeutica.
ES8606245A1 (es) Procedimiento para preparar fenoxianilinas y piridiloxianilinas sustituidas
FI943360A (fi) Propoksibentseenijohdannaisia